These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
4. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833 [TBL] [Abstract][Full Text] [Related]
5. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people? Xu K; Wei Y; Giunta S; Zhou M; Xia S Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases. Tang XD; Ji TT; Dong JR; Feng H; Chen FQ; Chen X; Zhao HY; Chen DK; Ma WT Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884813 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19. Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145 [TBL] [Abstract][Full Text] [Related]
8. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE Front Immunol; 2021; 12():749291. PubMed ID: 34867978 [TBL] [Abstract][Full Text] [Related]
9. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm. Mahmoud IS; Jarrar YB; Febrimarsa Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574 [TBL] [Abstract][Full Text] [Related]
10. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α. Moasefi N; Fouladi M; Norooznezhad AH; Yarani R; Rahmani A; Mansouri K Inflamm Res; 2021 Jul; 70(7):749-752. PubMed ID: 34173853 [TBL] [Abstract][Full Text] [Related]
11. Fighting the storm: could novel anti-TNFα and anti-IL-6 Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050 [TBL] [Abstract][Full Text] [Related]
12. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Fazeli P; Saeidnia M; Erfani M; Kalani M Immunol Res; 2022 Jun; 70(3):316-324. PubMed ID: 35260945 [TBL] [Abstract][Full Text] [Related]
13. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Fara A; Mitrev Z; Rosalia RA; Assas BM Open Biol; 2020 Sep; 10(9):200160. PubMed ID: 32961074 [TBL] [Abstract][Full Text] [Related]
14. Cytokines and COVID-19: friends or foes? Rokni M; Hamblin MR; Rezaei N Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579 [TBL] [Abstract][Full Text] [Related]
15. Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series. Basnet A; Shrestha MR; Thapa R; Tamang B; Shrestha A; Rawal P; Duwal Shrestha SK; Karki L; Rai SK JNMA J Nepal Med Assoc; 2022 Aug; 60(252):727-731. PubMed ID: 36705224 [TBL] [Abstract][Full Text] [Related]
16. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and immunological aspects of COVID-19 infection and therapeutical intervention of oral low dose cytokine therapy: a systematic review. M R; S S; Jose SP; Rajan S; Thomas S; Jagmag T; Tilwani J Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):22-29. PubMed ID: 33106053 [TBL] [Abstract][Full Text] [Related]
18. High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs. Aswad M; Hamza H; Pechkovsky A; Zikrach A; Popov T; Zohar Y; Shahar E; Louria-Hayon I Front Immunol; 2022; 13():875546. PubMed ID: 35651623 [TBL] [Abstract][Full Text] [Related]
19. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications. Machado C; González-Quevedo A MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537 [TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]